Clinical experience with the management of schizophrenia in the general hospital

Psychosomatics

Volumn 44, Issue 1, 2003, Pages 12-23

  Freudenreich, Oliver ^a   Stern, Heodore A ^a  

^a Freedom Trail Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; ERYTHROMYCIN; FLUVOXAMINE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE;

AGRANULOCYTOSIS; AKINESIA; AWARENESS; COMPETENCE; CONSULTATION; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG WITHDRAWAL; DYSTONIA; ENDOCRINE DISEASE; EOSINOPHILIA; EXPERIENCE; EXTRAPYRAMIDAL SYMPTOM; FEAR; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL HOSPITAL; HEART FAILURE; HOMELESSNESS; HOSPITAL PERSONNEL; HUMAN; HYPERPROLACTINEMIA; ILLNESS BEHAVIOR; LEUKOPENIA; LIPID METABOLISM; LUNG EMBOLISM; MEDICAL EDUCATION; MENTAL HEALTH; MENTAL HEALTH CARE; METABOLIC DISORDER; NEUROLOGIC DISEASE; PARKINSONISM; PATIENT COMPLIANCE; PSYCHOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SAFETY; SCHIZOPHRENIA; SEPSIS; SUDDEN DEATH; SUICIDE; SURGICAL WARD; SYNCOPE; TARDIVE DYSKINESIA; UROGENITAL TRACT DISEASE;

EID: 0037222403     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.44.1.12     Document Type: Review

References (107)

1. Zöllner H-M: Psychiatrie in Lebens- und Leidensgeschichten. Stuttgart, Germany, Enke, 1997
2. Goff DC, Henderson DC, Manschreck TC: Psychotic patients, in Massachusetts General Hospital Handbook of General Hospital Psychiatry. Edited by Cassem NH. St Louis, Mosby, 1997, pp 149-171
3. Goff DC, Heckers S, Freudenreich O: Schizophrenia. Med Clin North Am 2001; 85:663-689
4. Vieweg V, Levenson J, Pandurangi A, Silverman J: Medical disorders in the schizophrenic patient. Int J Psychiatry Med 1995; 25:137-172
5. Goldman LS: Comorbid medical illness in psychiatric patients. Curr Psychiatry Rep 2000; 2:256-263
6. Gilmore JH, Jarskog LF, Stroup TS: Medical and surgical illness in patients with schizophrenia, in Schizophrenia and Comorbid Conditions: Diagnosis and Treatment. Edited by Hwang MY, Bermanzohn PC. Washington, DC, American Psychiatric Press, 2001, pp 95-112
7. Gilmore JH, Perkins DO, Lindsey BA: Factors related to psychiatric consultation for schizophrenic patients receiving medical care. Hosp Community Psychiatry 1994; 45:1233-1235
8. Lawrie SM, Martin K, McNeill G, Drife J, Chrystie P, Reid A, Wu P, Nammary S, Ball J: General practitioners' attitudes to psychiatric and medical illness. Psychol Med 1998; 28:1463-1467
9. Herzog DB, Wyshak G, Stem TA: Patient-generated dysphoria in house officers. J Med Educ 1984; 59:869-874
10. Buchanan A, Bhugra D: Attitude of the medical profession to psychiatry. Acta Psychiatr Scand 1992; 85:1-5
11. Furnham A, Bower P: A comparison of academic and lay theories of schizophrenia. Br J Psychiatry 1992; 161:201-210
12. Siris SG: Management of depression in schizophrenia. Psychiatr Annals 2000; 30:13-19
13. Siris SG: Depression in schizophrenia: Perspective in the era of "atypical" antipsychotic agents. Am J Psychiatry 2000; 157: 1379-1389
14. Farrell KR, Ganzini L: Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995; 155:2459-2464
15. Carpenter WT Jr, Heirichs DW, Alphs LD: Treatment of negative symptoms. Schizophr Bull 1985; 11:440-452
16. Slavney PR: Psychiatric Dimensions of Medical Practice: What Primary-Care Physicians Should Know About Delirium, Demoralization, Suicidal Thinking, and Competence to Refuse Medical Advice. Baltimore, Johns Hopkins University Press, 1998
17. Heilä H, Isometsä ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lönnqvist JK: Suicide and schizophrenia: A nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997; 154:1235-1242
18. Miller SC: Methylphenidate for clozapine sedation (letter). Am J Psychiatry 1996; 153: 1231-1232
19. Carpenter WT Jr, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS: Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 2000; 57:533-538
20. Wirshing DA, Wirshing WC, Marder SR, Liberman RP, Mintz J: Informed consent: Assessment of comprehension. Am J Psychiatry 1998; 155:1508-1511
21. McKenna PJ, Tamlyn D, Lund CE, Mortimer AM, Hammond S, Baddeley AD: Amnesic syndrome in schizophrenia. Psychol Med 1990; 20:967-972
22. Weinberger DR, Aloia MS, Goldberg TE, Berman KF: The frontal lobes and schizophrenia. J Neuropsychiatry Clin Neurosci 1994; 6:419-427; correction, 1995: 7:121
23. Schwartz CE, Steinmuller RI, Dubler N: The medical psychiatrist as physician for the chronically mentally ill. Gen Hosp Psychiatry 1998; 20:52-61
24. Cheadle J. Morgan R: Does the chronic psychiatric patient understand plain English? Br J Psychiatry 1972; 120:553-560
25. Henderson DC: Clozapine: Diabetes mellitus, weight gain, and lipid abnormalities. J Clin Psychiatry 2001; 62(suppl 23):39-44
26. Henderson DC, Cagliero E, Gray C, Nasrallah RS, Hayden DL, Schoenfeld DA, Goff DC: Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000; 157:975-981
27. Cerulli TR: Clozapine-associated pancreatitis. Harv Rev Psychiatry 1999; 7:61-63
28. Kostakoglu AE, Yazici KM, Erbas T, Guvener N: Ketoacidosis as a side-effect of clozapine: A case report. Acta Psychiatr Scand 1996; 93:217-218
29. Smith H, Kenney-Herbert J, Knowles L: Clozapine-induced diabetic ketoacidosis. Aust N Z J Psychiatry 1999; 33:120-121
30. Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced tardive dyskinesia and acute extra-pyramidal movement disorders. Arch Intern Med 1993; 153: 1469-1475
31. Rodgers C: Extrapyramidal side effects of antiemetics presenting as psychiatric illness. Gen Hosp Psychiatry 1992; 14:192-195
32. Kruk J, Sachdev P, Singh S: Neuroleptic-induced respiratory dyskinesia. J Neuropsychiatry Clin Neurosci 1995; 7:223-229
33. Arango C, Adami H, Sherr JD, Thaker GK, Carpenter WT Jr: Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry 1999; 156:1097-1099
34. Cozza KL, Armstrong SC: Concise Guide to the Cytochrome P450 System: Drug Interaction Principles for Medical Practice. Washington, DC, American Psychiatric Publishing, 2001
35. Goulden KJ, Dooley JM, Camfield PR, Fraser AD: Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 1987; 37:1392-1394
36. Schwartz SR, Goldfinger SM: The new chronic patient: Clinical characteristics of an emerging subgroup. Hosp Community Psychiatry 1981; 32:470-474
37. Koranyi EK: Morbidity and rate of undiagnosed physical illness in a psychiatric clinic population. Arch Gen Psychiatry 1979; 36:414-419
38. Lamdan RM, Ramchandani D, Schindler BA: The chronically mentally ill on a general hospital consultation-liaison service. Psychosomatics 1997; 38:472-477
39. Munk-Jorgensen P, Mors O, Mortensen PB, Ewald H: The schizophrenic patient in the somatic hospital. Acta Psychiatr Scand Suppl 2000; 102:96-99
40. Bunce DFM II, Jones LR, Badger LW, Jones SE: Medical illness in psychiatric patients: Barriers to diagnosis and treatment. South Med J 1982; 75:941-944
41. Pary RJ, Barton SN: Communication difficulty of patients with schizophrenia and physical illness. South Med J 1988; 81:489-490
42. Lawrence D, Holman CDJ, Jablensky AV, Threlfall TJ, Fuller SA: Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand 2000; 101:382-388
43. Yarden PE, Finkel MG, Raps CS, Girvan JJ: Adverse outcome of hip fractures in older schizophrenic patients. Am J Psychiatry 1989; 146:377-379
44. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM: Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000; 283:506-511
45. Tobias CR, Turns DM, Lippmann S, Pary R, Oropilla TB: Evaluation and management of self-mutilation. South Med J 1988; 81:1261-1263
46. Myers WC, Nguyen M: Autocastration as a presenting sign of incipient schizophrenia. Psychiatr Serv 2001; 52:685-686
47. Tavcar R, Dernovsek MZ, Zwan V: Self-amputation of left hand: A case report (letter). J Clin Psychiatry 1999; 60:793-794
48. Greilsheimer H, Groves JE: Male genital self-mutilation. Arch Gen Psychiatry 1979; 36:441-446
49. Zisook S, Byrd D, Kuck J, Jeste DV: Command hallucinations in outpatients with schizophrenia. J Clin Psychiatry 1995; 56: 462-465
50. Hem E, Steen O, Opjordsmoen S: Thrombosis associated with physical restraints. Acta Psychiatr Scand 2001; 103:73-76
51. Freudenreich O, Goff DC: Colon perforation and peritonitis associated with clozapine (letter). J Clin Psychiatry 2000; 61:950-951
52. Killian JG, Kerr K, Lawrence C, Celermajer DS: Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841-1845
53. La Grenade L, Graham D, Trontell A: Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med 2001; 345:224-225
54. Stanilla JK, de Leon J, Simpson GM: Clozapine withdrawal resulting in delirium with psychosis: A report of three cases. J Clin Psychiatry 1997; 58:252-255
55. Lieberman JA, Kane JM, Johns CA: Clozapine: Guidelines for clinical management, J Clin Psychiatry 1989; 50:329-338
56. Daly JM, Goldberg RJ, Braman SS: Polyserositis associated with clozapine treatment (letter). Am J Psychiatry 1992; 149:1274-1275
57. Chatterton R: Eosinophilia after commencement of clozapine treatment. Aust N Z J Psychiatry 1997; 31:874-876
58. Walker AM, Lanza LL, Arellano F, Rothman KJ: Mortality in current and former users of clozapine. Epidemiology 1997; 8: 671-677
59. Hagg S, Spigset O, Soderstrom TG: Association of venous thromboembolism and clozapine. Lancet 2000; 355:1155-1156
60. Fraser D, Jibani M: An unexpected and serious complication of treatment with the atypical antipsychotic drug clozapine. Clin Nephrol 2000; 54:78-80
61. Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR: Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996; 22:591-595
62. Spemer-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW: Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF): Remission despite continuous treatment with clozapine. Br J Psychiatry 1998; 172:82-84
63. de Leon J, Stanilla JK, White AO, Simpson GM: Anticholinergics to treat clozapine withdrawal (letter). J Clin Psychiatry 1994; 55:119-120
64. McKenna RC, Bailey L, Haake J, Desai PN, Prasad BR: Clozapine and chemotherapy (letter). Hosp Community Psychiatry 1994; 45:831
65. Miller PR: Clozapine therapy for a patient with a history of Hodgkin's disease. Psychiatr Serv 2001; 52:110-111
66. Henderson DC, Borba CP: Trimethoprim-sulfamethoxazole and clozapine. Psychiatr Serv 2001; 52:111-112
67. Freudenreich O, Weiner RD, McEvoy JP: Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 1997; 42:132-137
68. Dumortier G, Lochu A, Colen de Melo P, Ghribi O, Roche Rabreau D, Degrassat K, Desce JM: Elevated clozapine plasma concentrations after fluvoxamine initiation (letter). Am J Psychiatry 1996; 153:738-739
69. Wise MG, Trzepacz PT: Delirium (confusional states), in The American Psychiatric Press Textbook of Consultation-Liaison Psychiatry. Edited by Rundell JR, Wise MG. Washington, DC, American Psychiatric Press, 1996, pp 258-274
70. Menza MA, Murray GB, Holmes VF, Rafuls WA: Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280
71. Hunt N, Stem TA: The association between intravenous haloperidol and torsades de pointes: Three cases and a literature review. Psychosomatics 1995; 36:541-549
72. Glassman AH, Bigger JT Jr: Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158:1774-1782
73. Torres R, Mittal D, Kennedy R: Use of quetiapine in delirium: Case reports. Psychosomatics 2001; 42:347-349
74. Tesar GE: Neuroleptic malignant syndrome: An update. Problems in Critical Care 1988; 2:149-158
75. Mashimo K, Kanaya M, Yamauchi T: Electroconvulsive therapy for a schizophrenic patient in catatonic stupor with joint contracture. Convuls Ther 1995; 11:216-219
76. Prager L, Millham F, Stern TA: Neuroleptic malignant syndrome: A review for intensivists. J Intensive Care Med 1994; 9:227-234
77. Tsai G, Crisostomo G, Rosenblatt ML, Stern TA: Neuroleptic malignant syndrome associated with clozapine treatment. Ann Clin Psychiatry 1995; 7:91-95
78. Rosebush PI, Stewart TD, Gelenberg AJ: Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry 1989; 50:295-298
79. Ungvari GS, Leung CM, Wong MK, Lau J: Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994; 89:285-288
80. Fink M: Neuroleptic malignant syndrome and catatonia: One entity or two? Biol Psychiatry 1996; 39:1-4
81. White DAC: Catatonia and the neuroleptic malignant syndrome - A single entity? Br J Psychiatry 1992; 161:558-560
82. Fricchione G, Bush G, Fozdar M, Francis A, Fink M: Recognition and treatment of the catatonic syndrome. J Intensive Care Med 1997; 12:135-147
83. Rosebush PI, Stewart T, Mazurek MF: The treatment of neuroleptic malignant syndrome: are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry 1991; 159:709-712
84. Illowsky BP, Kirch DG: Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145:675-683
85. Vieweg WV: Behavioral approaches to polydipsia. Biol Psychiatry 1993; 34:125-127
86. Yassa R, Iskandar H, Nastase C, Camille Y: Carbamazepine and hyponatremia in patients with affective disorders. Am J Psychiatry 1988; 145:339-342
87. Strachan J, Shepherd J: Hyponatremia associated with the use of selective serotonin reuptake inhibitors. Aust N Z J Psychiatry 1998; 32:295-298
88. Allon M, Allen HM, Deck LV, Clark ML: Role of cigarette use in hyponatremia in schizophrenic patients. Am J Psychiatry 1990; 147:1075-1077
89. Goldman MB, Luchins DJ: Demeclocycline improves hyponatremia in chronic schizophrenics. Biol Psychiatry 1985; 20:1149-1155
90. Henderson D, Goff DC: Clozapine for polydipsia and hyponatremia in chronic schizophrenics. Biol Psychiatry 1994; 36:768-770
91. Goldman MB: A rational approach to disorders of water balance in psychiatric patients. Hosp Community Psychiatry 1991; 42: 488-494
92. Goldman MB, Robertson GL, Luchins DJ, Hedeker D, Pandey GN: Psychotic exacerbations and enhanced secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 1997; 54:443-449
93. Goldman MB, Luchins DJ, Robertson GL: Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988; 318:397-403
94. Siegel AJ, Baldessarihi RJ, Klepser MB, McDonald JC: Primary and drug-induced disorders of water homeostasis in psychiatric patients: Principles of diagnosis and management. Harv Rev Psychiatry 1998; 6:190-200
95. Docherty JP, van Kammen DP, Siris SG, Marder SR: Stages of onset of schizophrenic psychosis. Am J Psychiatry 1978; 135: 420-426
96. Fava GA, Kellner R: Staging: A neglected dimension in psychiatric classification. Acta Psychiatr Scand 1993; 87:225-230
97. Heinrichs DW, Carpenter WT Jr: Prospective study of prodromal symptoms in schizophrenic relapse. Am J Psychiatry 1985; 142:371-373
98. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF: Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 1999; 156:299-303
99. Greeman M, McClellan TA: Negative effects of a smoking ban on an inpatient psychiatry service. Hosp Community Psychiatry 1991; 42:408-412
100. Velasco J, Eells TD, Anderson R, Head M, Ryabik B, Mount R, Lippmann S: A two-year follow-up on the effects of a smoking ban in an inpatient psychiatric service. Psychiatr Serv 1996; 47:869-871
101. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA: Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143:993-997
102. Desai HD, Seabolt J, Jann MW: Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs 2001; 15:469-494
103. Seppala NH, Leinonen EV, Lehtonen ML, Kivisto KT: Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients. Pharmacol Toxicol 1999; 85:244-246
104. Goff DC, Henderson DC, Amico E: Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149:1189-1194
105. Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177:212-217
106. Addington J, el Guebaly N, Campbell W, Hodgins DC, Addington D: Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry 1998; 155:974-976
107. Rigotti NA, Arnsten JH, McKool KM, Wood-Reid KM, Singer DE, Pasternak RC: The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med 1999; 17:255-259